I have thoroughly verified the paper's content against each reviewer claim. Let me now produce the final consolidated review.

---

## Summary

This paper proposes a rule-based alignment algorithm for VLMs in medical domains. The key idea is to formalize clinical reasoning as a decision tree, then use this representation to (i) automatically synthesize multi-turn clinician-VLM conversations for instruction tuning, and (ii) derive a rule-based reward function that evaluates both per-turn correctness and cross-turn clinical consistency — replacing the human feedback typically required in RLHF. The authors apply this to bone marrow pathology, developing Dr-LLaVA (based on LLaVA). Results on synthetic multi-turn conversations show Dr-LLaVA outperforming SFT-only baselines on question-level accuracy, conversation-level accuracy, and diagnostic accuracy, and being more robust to misleading clinician prompts.

## Strengths

1. **Rule-based automatic data generation and reward modeling that eliminates per-example human annotation.** The paper proposes a complete pipeline where a formalized decision tree (Fig. 3) is used to automatically synthesize multi-turn clinician-VLM conversations (Section 2.1) and to derive a reward function requiring no human feedback (Section 2.2). This directly addresses the annotation bottleneck that limits RLHF in medical domains, as noted in the introduction.

2. **Explicit handling of context-conflicting hallucination via a novel rule-based consistency reward.** The reward function includes a term \(R_S\) that evaluates whether the VLM's entire sequence of responses follows a clinically valid reasoning path. The paper shows that removing this consistency reward (Table 3) degrades both correctness and conversation-level accuracy, and the ablation in Fig. 5 demonstrates the trade-off between accuracy and consistency.

3. **Strong empirical performance across diverse conversational scenarios.** In Table 1, Dr-LLaVA outperforms all baselines in every metric for standard (SI), inverted (DF), and randomized (II) question sequences. Table 2 shows Dr-LLaVA disagrees with misleading clinician prompts more often than baselines (e.g., 83.3% vs. 68.8% on Rationalization Queries with wrong hypotheses). These results support the claim that rule-based grounding improves robustness.

4. **Comprehensive ablation isolating each reward component.** Table 3 measures the impact of removing correctness reward, consistency reward, length penalty, and no-match penalty separately, providing evidence that each term serves a distinct purpose. The qualitative examples in Fig. 4 support the quantitative findings.

## Weaknesses

### Fatal
None.

### Major

1. **Evaluation is entirely on synthetic, in-distribution data with no external validation.** All training data, test data, and evaluation metrics derive from the same underlying rule structure and template set. The test set shares the same annotation protocol, rule structure, and template phrasings as the training set. The paper acknowledges using synthetic data but does not discuss how this limits generalizability. Without any evaluation on real clinician-VLM interactions, out-of-distribution images (e.g., from different institutions, scanners, or staining protocols), or human clinician ratings, the performance claims only characterize in-distribution pattern matching on synthetic conversations — not clinically valid reasoning in real settings. This is the most significant limitation of the work.

### Minor

2. **The keyword-matching reward function is underspecified.** The paper mentions an "efficient keyword-matching algorithm" that maps VLM free-text outputs to discrete diagnostic categories but provides no details about how it handles paraphrases, spelling variations, negations, or partial matches, nor any accuracy characterization on a held-out set. Without this, the reliability of the reward signal and the reproducibility of the method are unclear.

3. **No human evaluation by clinicians.** All evaluations rely on automated metrics tied to the synthetic data. The most direct evidence for "clinically valid and consistent responses" would come from clinician ratings of response correctness, coherence, and trustworthiness. Its absence substantially weakens the clinical utility claims.

4. **No confidence intervals or statistical significance.** Tables 1, 2, and 3 report single-run results without error bars or significance tests. With a single seed, observed differences (especially in ablation studies) could reflect noise rather than meaningful effects. This is standard for large-scale RL experiments but should be acknowledged.

5. **Limited diagnostic scope.** The dataset covers only five conditions (blood contamination, particle-enriched contamination, AML, multiple myeloma, healthy) from a single institution. The paper does not discuss whether the approach scales to dozens or hundreds of possible findings or to multi-site data.

6. **No systematic error or failure mode analysis.** The qualitative example in Fig. 4 is a single case. The paper would benefit from a systematic breakdown of when and why Dr-LLaVA fails (e.g., breakdown by condition, question type, image quality). The absence of a limitations discussion is also notable.

### Trivial
None.

## Nice-to-Haves

- Adding a direct comparison showing Dr-LLaVA's SFT checkpoint (π_SFT^φ) before RL vs. after RL, to further isolate the RL contribution beyond what LLaVA-SFT already provides.
- Release of the rule definitions, synthesized dataset, and evaluation code for independent replication and extension to other domains.
- Probing generalization to images from a different medical center or to a small set of real clinician-VLM interactions collected post-hoc, even at small scale.
- Analysis of how often Dr-LLaVA produces correct final diagnoses despite incorrect intermediate answers, or appropriately refuses to answer when image quality is poor.

## Removed Points

These points were flagged for removal after cross-checking against the paper; they are listed here for traceability but should not be treated as valid weaknesses.

- **"Absence of comparison with the SFT-only version of the same model"** — Factually incorrect. LLaVA-SFT is listed as a baseline in Table 1 and uses the same architecture (LLaVA) with SFT on the same data. Dr-LLaVA = LLaVA + SFT + RL. The comparison LLaVA-SFT vs. Dr-LLaVA IS the architecture-controlled comparison isolating the RL effect. The paper states: "we base Dr-LLaVA on the same model architecture as LLaVA" (line 121) and baselines undergo SFT on "our synthesized conversational data over four epochs" (line 127).

- **"Circular evaluation with the reward design"** — Overstated. The reward \(R_C\) (per-turn correctness) and the metric \(A_Q\) (question-level accuracy) both measure whether responses match ground truth, but this is by design: you define a reward for what you want, optimize for it with RL, and measure it on a held-out test set. The held-out split prevents overfitting. This is standard RL practice, not circular reasoning. The valid kernel of this concern (synthetic data evaluation) is captured in Major Weakness #1.

- **"Manual engineering cost as a weakness"** — The paper explicitly acknowledges that the rules were designed by an expert pathologist and frames this upfront knowledge engineering as a one-time cost that eliminates per-example human annotation. The trade-off is clearly stated. This is not a weakness but the method's premise.

- **"H_cc is essentially the inverse of consistency reward"** — This observation is factually correct but not a weakness. The consistency reward \(R_S\) evaluates whether the conversation maps to a valid rule, and \(H_{cc}\) measures the fraction mapping to invalid rules. They are related by design — the ablation in Fig. 5 characterizes precisely this relationship under different \(\lambda\) values, which is informative.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

1. **Add a human evaluation component.** Even a small-scale study with one or two clinicians rating a sample of Dr-LLaVA and baseline responses (e.g., 50 conversations) on correctness, clinical coherence, and trustworthiness would substantially strengthen the claims.
2. **Characterize the keyword-matching reward's accuracy.** Provide precision/recall on a held-out set of human-written responses, or at minimum describe the matching algorithm in sufficient detail for reproduction.
3. **Report results with error bars** (e.g., across multiple random seeds or bootstrap resampling of the test set).
4. **Include a brief limitations section** discussing when the rule-based approach may fail (incomplete rules, edge cases, ambiguous images) and how the synthetic evaluation limits generalizability claims.
5. **Add a breakdown of errors by diagnostic category and question type** to help interpret the aggregate metrics.

## Score and Decision

MY FINAL SCORE: <pineapple>6.0</pineapple>
MY FINAL DECISION: <orange>Accept</orange>